Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A.

J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14.

PMID:
19365596
2.

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.

Muros MA, Varsavsky M, Iglesias Rozas P, Valdivia J, Delgado JR, Forrer F, Bodei L, Paganelli G.

Clin Transl Oncol. 2009 Jan;11(1):48-53.

PMID:
19155204
3.

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO, Krenning EP.

J Clin Oncol. 2008 May 1;26(13):2124-30. doi: 10.1200/JCO.2007.15.2553.

PMID:
18445841
4.

Prognostic factors in gastrointestinal endocrine tumors.

Rindi G, D'Adda T, Froio E, Fellegara G, Bordi C.

Endocr Pathol. 2007 Fall;18(3):145-9. Review.

PMID:
18058263
5.

Receptor PET/CT imaging of neuroendocrine tumors.

Baum RP, Prasad V, Hommann M, Hörsch D.

Recent Results Cancer Res. 2008;170:225-42. Review. No abstract available.

PMID:
18019630
6.

Pancreatic neuroendocrine tumours.

O'Grady HL, Conlon KC.

Eur J Surg Oncol. 2008 Mar;34(3):324-32. Epub 2007 Oct 29. Review.

PMID:
17967523
7.

Radio-guided surgery in neuroendocrine tumors.

Gulec SA, Baum R.

J Surg Oncol. 2007 Sep 15;96(4):309-15. Review.

PMID:
17726664
8.

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

Wehrmann C, Senftleben S, Zachert C, Müller D, Baum RP.

Cancer Biother Radiopharm. 2007 Jun;22(3):406-16.

PMID:
17651048
9.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B; all other Frascati Consensus Conference participants.; European Neuroendocrine Tumor Society (ENETS)..

Virchows Arch. 2006 Oct;449(4):395-401. Epub 2006 Sep 12.

10.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
11.

Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT.

Zhernosekov K, Aschoff P, Filosofov D, Jahn M, Jennewein M, Adrian HJ, Bihl H, Rösch F.

Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1129. No abstract available.

PMID:
16133389
12.

[Tumors of the endocrine pancreas].

Anlauf M, Sipos B, Klöppel G.

Pathologe. 2005 Feb;26(1):46-51. German.

PMID:
15586284
13.

Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Dralle H, Krohn SL, Karges W, Boehm BO, Brauckhoff M, Gimm O.

World J Surg. 2004 Dec;28(12):1248-60. Epub 2004 Nov 11. Review.

PMID:
15517487
14.

Aggressive surgery for metastatic liver neuroendocrine tumors.

Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT.

Surgery. 2003 Dec;134(6):1057-63; discussion 1063-5.

PMID:
14668741
15.

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.

Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, De Jong M, Wenger S, Reubi JC.

Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47. Epub 2003 Aug 21.

PMID:
12937948
16.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
17.

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.

Jamar F, Barone R, Mathieu I, Walrand S, Labar D, Carlier P, de Camps J, Schran H, Chen T, Smith MC, Bouterfa H, Valkema R, Krenning EP, Kvols LK, Pauwels S.

Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):510-8. Epub 2003 Feb 12.

PMID:
12582815

Supplemental Content

Support Center